Disc Medicine to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Disc Medicine (NASDAQ:IRON) announced management will present at multiple investor conferences in early March 2026, including TD Cowen (Mar 3), Leerink Global Healthcare (Mar 9), Jefferies Biotech on the Beach (Mar 10) and Barclays Healthcare (Mar 11).

Live webcasts of the presentations will be accessible via the company's investor relations website and archived replays will be available after each event.

News Market Reaction – IRON

+3.44%

1 alert

+3.44% News Effect

On the day this news was published, IRON gained 3.44%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WATERTOWN, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will present at two upcoming investor conferences:

• TD Cowen 46^th Annual Health Care Conference on Tuesday, March 3^rd at 9:50 a.m. ET in Boston, MA.
  
• Leerink Global Healthcare Conference on Monday, March 9^th at 3:40 p.m. ET in Miami, FL.
  
  

Disc management will be participating in investor meetings during the above conferences, as well as the Jefferies Biotech on the Beach Summit on March 10^th and the Barclays 28^th Annual Global Healthcare Conference on March 11^th, both in Miami, FL.

Live webcasts of the presentations will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.

About Disc Medicine

Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.

Media Contact

Peg Rusconi
Deerfield Group
peg.rusconi@deerfieldgroup.com

Investor Relations Contact

Christina Tartaglia
Precision AQ
christina.tartaglia@precisionaq.com

FAQ

When will Disc Medicine (NASDAQ:IRON) present at the TD Cowen conference in 2026?

Disc Medicine will present at TD Cowen on March 3, 2026 at 9:50 a.m. ET. According to the company, management will present in Boston and make a live webcast available via the investor relations website for remote viewers.

What time is Disc Medicine's (IRON) presentation at the Leerink Global Healthcare Conference?

Disc Medicine is scheduled to present on March 9, 2026 at 3:40 p.m. ET. According to the company, the presentation is in Miami and a live webcast plus archived replay will be posted on its investor relations site.

Will Disc Medicine (IRON) webcast its March 2026 investor conference presentations?

Yes, Disc Medicine will provide live webcasts and archived replays of its conference presentations. According to the company, webcasts are available through the investor relations section at ir.discmedicine.com for on‑demand viewing after each event.

Which additional investor conferences will Disc Medicine (NASDAQ:IRON) attend in March 2026?

Disc Medicine will participate in Jefferies Biotech on the Beach (Mar 10) and Barclays 28th Annual Global Healthcare (Mar 11). According to the company, management will hold investor meetings at those Miami events.

How can investors access Disc Medicine (IRON) presentation replays after the March 2026 conferences?

Investors can access archived replays via the company's investor relations website at ir.discmedicine.com. According to the company, replays will be posted after each presentation for on‑demand viewing by investors and analysts.

Are Disc Medicine's (IRON) March 2026 conference presentations focused on clinical progress or corporate updates?

The announcement lists conference participation and webcast availability but does not specify presentation content. According to the company, management will present and meet with investors at the listed healthcare conferences in early March 2026.